Safety and Feasibility Study of NST - 001 in Inner Ear Using Neuroject Injection Set for the Treatment of Tinnitus
This research study involves an experimental drug (NST_001) and a delivery system. The main purpose of this research study is to investigate the safety of NST-001, delivered directly to the inner ear for the treatment of tinnitus.
100 Clinical Results associated with Neurosystec Corp.
0 Patents (Medical) associated with Neurosystec Corp.
100 Deals associated with Neurosystec Corp.
100 Translational Medicine associated with Neurosystec Corp.